Exploring the current and future role of artificial intelligence in pharmaceutical market access: insights from a European survey
Abstract Introduction Artificial Intelligence (AI) is rapidly expanding across the pharmaceutical value chain; however, empirical evidence on its application in Market Access (MA) remains limited. Given the strategic relevance and regulatory complexity of MA, understanding current AI adoption and perception represents...